Evidence map›Paper›PMID 27531960›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Holdase activity of secreted Hsp70 masks amyloid-β42 neurotoxicity in Drosophila.

Pedro Fernandez-Funez, Jonatan Sanchez-Garcia, Lorena de Mena, Yan Zhang, Yona Levites, Swati Khare, Todd E Golde, Diego E Rincon-Limas

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Structures of the 26Science advances · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Pedro Fernandez-FunezDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL 32611; Department of Neuroscience, Center for Translational Research on Neurodegenerative Diseases, University of Florida, Gainesville, FL 32611; Genetics Institute, University of Florida, Gainesville, FL 32611 pedro.ffunez@gmail.com diego.rincon@neurology.ufl.edu.
Jonatan Sanchez-GarciaDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL 32611;
Lorena de MenaDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL 32611;
Yan ZhangDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL 32611;
Yona LevitesDepartment of Neuroscience, Center for Translational Research on Neurodegenerative Diseases, University of Florida, Gainesville, FL 32611;
Swati KhareDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL 32611;
Todd E GoldeDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL 32611; Department of Neuroscience, Center for Translational Research on Neurodegenerative Diseases, University of Florida, Gainesville, FL 32611;
Diego E Rincon-LimasDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL 32611; Department of Neuroscience, Center for Translational Research on Neurodegenerative Diseases, University of Florida, Gainesville, FL 32611; Genetics Institute, University of Florida, Gainesville, FL 32611 pedro.ffunez@gmail.com diego.rincon@neurology.ufl.edu.
University of Florida · US

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Cale Whitworth · 2014 to 2026
$13.5M
Mechanisms of Prion MisfoldingDP2OD002721 · OD · UNIVERSITY OF TEXAS MED BR GALVESTON · PI FERNANDEZ-FUNEZ, PEDRO · 2007 to 2010
$2.2M
Engineering chaperones for extracellular amyloidsR21NS081356 · NINDS · UNIVERSITY OF FLORIDA · PI RINCON-LIMAS, DIEGO E · 2013 to 2014
$411k
NIH HHS DP2 OD002721NIH HHS P40 OD018537NINDS NIH HHS R21 NS081356
6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most prevalent of a large group of related proteinopathies for which there is currently no cure. Here, we used Drosophila to explore a strategy to block Aβ42 neurotoxicity through engineering of the Heat shock protein 70 (Hsp70), a chaperone that has demonstrated neuroprotective activity against several intracellular amyloids. To target its protective activity against extracellular Aβ42, we added a signal peptide to Hsp70. This secreted form of Hsp70 (secHsp70) suppresses Aβ42 neurotoxicity in adult eyes, reduces cell death, protects the structural integrity of adult neurons, alleviates locomotor dysfunction, and extends lifespan. SecHsp70 binding to Aβ42 through its holdase domain is neuroprotective, but its ATPase activity is not required in the extracellular space. Thus, the holdase activity of secHsp70 masks Aβ42 neurotoxicity by promoting the accumulation of nontoxic aggregates. Combined with other approaches, this strategy may contribute to reduce the burden of AD and other extracellular proteinopathies.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsAnimals, Genetically ModifiedDisease Models, AnimalDrosophila melanogasterEyeFemaleGenetic EngineeringHEK293 CellsHSP70 Heat-Shock ProteinsHumansLongevityMaleMotor DisordersNeuronsAmyloid beta-Peptidesamyloid beta-protein (1-42)HSP70 Heat-Shock ProteinsPeptide Fragmentsamyloid-βDrosophilaengineered chaperonesHsp70neuroprotections

Identifiers

PMID27531960
PMCPMC5024614
OpenAlexW2518303202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.